Annual gross profit:
$43.87B+$6.32B(+16.84%)Summary
- As of today (April 13, 2025), AZN annual gross profit is $43.87 billion, with the most recent change of +$6.32 billion (+16.84%) on December 31, 2024.
- During the last 3 years, AZN annual gross profit has risen by +$18.89 billion (+75.60%).
- AZN annual gross profit is now at all-time high.
Performance
AZN Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$12.17B+$1.68B(+16.04%)Summary
- As of today (April 13, 2025), AZN quarterly gross profit is $12.17 billion, with the most recent change of +$1.68 billion (+16.04%) on December 31, 2024.
- Over the past year, AZN quarterly gross profit has stayed the same.
- AZN quarterly gross profit is now at all-time high.
Performance
AZN quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$43.87B+$2.45B(+5.92%)Summary
- As of today (April 13, 2025), AZN TTM gross profit is $43.87 billion, with the most recent change of +$2.45 billion (+5.92%) on December 31, 2024.
- Over the past year, AZN TTM gross profit has stayed the same.
- AZN TTM gross profit is now at all-time high.
Performance
AZN TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
AZN Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | 0.0% | 0.0% |
| 3 y3 years | +75.6% | +56.5% | +50.5% |
| 5 y5 years | +125.4% | +56.5% | +50.5% |
AZN Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.6% | at high | +56.5% | at high | +60.1% |
| 5 y | 5-year | at high | +125.4% | at high | +146.6% | at high | +119.0% |
| alltime | all time | at high | +372.3% | at high | +1038.0% | at high | +4003.1% |
AstraZeneca Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $43.87B(+16.8%) | $12.17B(+16.0%) | $43.87B(+5.9%) |
| Sep 2024 | - | $10.48B(-2.5%) | $41.42B(+2.7%) |
| Jun 2024 | - | $10.76B(+2.8%) | $40.33B(+3.3%) |
| Mar 2024 | - | $10.46B(+7.7%) | $39.03B(+4.0%) |
| Dec 2023 | $37.54B(+17.5%) | $9.72B(+3.4%) | $37.54B(+3.9%) |
| Sep 2023 | - | $9.40B(-0.6%) | $36.13B(+4.0%) |
| Jun 2023 | - | $9.46B(+5.4%) | $34.74B(+5.1%) |
| Mar 2023 | - | $8.97B(+8.0%) | $33.05B(+3.4%) |
| Dec 2022 | $31.96B(+27.9%) | $8.31B(+3.8%) | $31.96B(+3.0%) |
| Sep 2022 | - | $8.00B(+2.9%) | $31.04B(+6.5%) |
| Jun 2022 | - | $7.77B(-1.3%) | $29.15B(+6.4%) |
| Mar 2022 | - | $7.88B(+6.7%) | $27.40B(+9.7%) |
| Dec 2021 | $24.98B(+17.2%) | $7.39B(+20.9%) | $24.98B(+6.4%) |
| Sep 2021 | - | $6.11B(+1.3%) | $23.48B(+4.0%) |
| Jun 2021 | - | $6.03B(+10.5%) | $22.58B(+3.4%) |
| Mar 2021 | - | $5.46B(-7.3%) | $21.84B(+2.4%) |
| Dec 2020 | $21.32B(+9.5%) | $5.88B(+13.0%) | $21.32B(+2.9%) |
| Sep 2020 | - | $5.21B(-1.6%) | $20.72B(+0.7%) |
| Jun 2020 | - | $5.29B(+7.2%) | $20.57B(+2.7%) |
| Mar 2020 | - | $4.93B(-6.7%) | $20.04B(+2.9%) |
| Dec 2019 | $19.46B(+13.5%) | $5.29B(+4.6%) | $19.46B(+2.7%) |
| Sep 2019 | - | $5.05B(+6.2%) | $18.96B(+4.8%) |
| Jun 2019 | - | $4.76B(+9.1%) | $18.09B(+3.5%) |
| Mar 2019 | - | $4.36B(-8.7%) | $17.47B(+1.9%) |
| Dec 2018 | $17.15B(-5.5%) | $4.78B(+14.2%) | $17.15B(+1.3%) |
| Sep 2018 | - | $4.19B(+1.1%) | $16.93B(-4.5%) |
| Jun 2018 | - | $4.14B(+2.4%) | $17.72B(+0.2%) |
| Mar 2018 | - | $4.04B(-11.2%) | $17.68B(-2.6%) |
| Dec 2017 | $18.15B(-3.9%) | $4.55B(-8.6%) | $18.15B(+0.7%) |
| Sep 2017 | - | $4.98B(+21.5%) | $18.02B(+1.0%) |
| Jun 2017 | - | $4.10B(-9.1%) | $17.84B(-2.4%) |
| Mar 2017 | - | $4.51B(+1.9%) | $18.28B(-3.2%) |
| Dec 2016 | $18.88B(-5.9%) | $4.42B(-7.8%) | $18.88B(-3.6%) |
| Sep 2016 | - | $4.80B(+5.7%) | $19.58B(-0.5%) |
| Jun 2016 | - | $4.54B(-11.2%) | $19.69B(-3.4%) |
| Mar 2016 | - | $5.11B(-0.4%) | $20.39B(+1.6%) |
| Dec 2015 | $20.06B(-3.1%) | $5.13B(+4.6%) | $20.06B(+0.4%) |
| Sep 2015 | - | $4.90B(-6.4%) | $19.98B(-1.4%) |
| Jun 2015 | - | $5.24B(+9.4%) | $20.27B(-1.0%) |
| Mar 2015 | - | $4.79B(-5.2%) | $20.49B(-1.1%) |
| Dec 2014 | $20.70B(+0.8%) | $5.05B(-2.8%) | $20.70B(-2.1%) |
| Sep 2014 | - | $5.19B(-4.8%) | $21.16B(+0.9%) |
| Jun 2014 | - | $5.46B(+8.9%) | $20.97B(+2.6%) |
| Mar 2014 | - | $5.01B(-8.9%) | $20.43B(-0.5%) |
| Dec 2013 | $20.55B(-9.0%) | $5.50B(+9.7%) | $20.55B(-1.8%) |
| Sep 2013 | - | $5.01B(+2.0%) | $20.93B(-1.9%) |
| Jun 2013 | - | $4.92B(-4.0%) | $21.33B(-1.8%) |
| Mar 2013 | - | $5.12B(-13.0%) | $21.73B(-3.8%) |
| Dec 2012 | $22.58B(-18.1%) | $5.88B(+8.8%) | $22.58B(-4.9%) |
| Sep 2012 | - | $5.41B(+1.8%) | $23.74B(-4.9%) |
| Jun 2012 | - | $5.31B(-11.0%) | $24.95B(-6.1%) |
| Mar 2012 | - | $5.97B(-15.2%) | $26.59B(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $27.57B(+2.5%) | $7.04B(+6.4%) | $27.57B(+0.7%) |
| Sep 2011 | - | $6.62B(-4.7%) | $27.38B(+0.9%) |
| Jun 2011 | - | $6.95B(-0.1%) | $27.13B(+0.8%) |
| Mar 2011 | - | $6.95B(+1.4%) | $26.91B(+0.1%) |
| Dec 2010 | $26.88B(-0.6%) | $6.86B(+7.6%) | $26.88B(-1.5%) |
| Sep 2010 | - | $6.37B(-5.2%) | $27.30B(-2.0%) |
| Jun 2010 | - | $6.73B(-2.8%) | $27.86B(+0.8%) |
| Mar 2010 | - | $6.92B(-4.9%) | $27.63B(+2.2%) |
| Dec 2009 | $27.03B(+8.1%) | $7.28B(+4.9%) | $27.03B(+4.6%) |
| Sep 2009 | - | $6.94B(+6.8%) | $25.83B(+3.0%) |
| Jun 2009 | - | $6.49B(+2.8%) | $25.08B(-0.1%) |
| Mar 2009 | - | $6.32B(+3.9%) | $25.11B(+0.4%) |
| Dec 2008 | $25.00B(+8.1%) | $6.08B(-1.8%) | $25.00B(+0.2%) |
| Sep 2008 | - | $6.19B(-5.1%) | $24.95B(+1.8%) |
| Jun 2008 | - | $6.53B(+5.1%) | $24.51B(+3.0%) |
| Mar 2008 | - | $6.21B(+3.0%) | $23.79B(+2.8%) |
| Dec 2007 | $23.14B(+10.6%) | $6.03B(+4.9%) | $23.14B(+2.0%) |
| Sep 2007 | - | $5.75B(-1.0%) | $22.69B(+2.6%) |
| Jun 2007 | - | $5.80B(+4.4%) | $22.12B(+2.4%) |
| Mar 2007 | - | $5.56B(-0.3%) | $21.60B(+3.3%) |
| Dec 2006 | $20.92B(+12.5%) | $5.58B(+7.7%) | $20.92B(+3.4%) |
| Sep 2006 | - | $5.18B(-2.1%) | $20.24B(+3.2%) |
| Jun 2006 | - | $5.29B(+8.5%) | $19.61B(+2.5%) |
| Mar 2006 | - | $4.88B(-0.5%) | $19.14B(+2.9%) |
| Dec 2005 | $18.59B(+14.5%) | $4.90B(+7.8%) | $18.59B(+3.3%) |
| Sep 2005 | - | $4.54B(-5.7%) | $18.00B(+3.2%) |
| Jun 2005 | - | $4.82B(+11.2%) | $17.43B(+4.7%) |
| Mar 2005 | - | $4.33B(+0.7%) | $16.65B(+2.6%) |
| Dec 2004 | $16.23B(+12.8%) | $4.30B(+8.1%) | $16.23B(+3.0%) |
| Sep 2004 | - | $3.98B(-1.4%) | $15.76B(+2.4%) |
| Jun 2004 | - | $4.04B(+3.1%) | $15.39B(+4.7%) |
| Mar 2004 | - | $3.92B(+2.4%) | $14.70B(+2.2%) |
| Dec 2003 | $14.39B(+8.0%) | $3.82B(+6.0%) | $14.39B(+1.1%) |
| Sep 2003 | - | $3.61B(+7.8%) | $14.23B(+3.3%) |
| Jun 2003 | - | $3.35B(-7.2%) | $13.77B(+0.7%) |
| Mar 2003 | - | $3.61B(-1.7%) | $13.67B(+2.7%) |
| Dec 2002 | $13.32B(+10.8%) | $3.67B(+16.6%) | $13.32B(+3.4%) |
| Sep 2002 | - | $3.15B(-3.2%) | $12.89B(+2.1%) |
| Jun 2002 | - | $3.25B(0.0%) | $12.62B(+2.1%) |
| Mar 2002 | - | $3.25B(+0.6%) | $12.36B(+2.9%) |
| Dec 2001 | $12.02B(+1.2%) | $3.23B(+12.1%) | $12.01B(+36.8%) |
| Sep 2001 | - | $2.89B(-3.4%) | $8.78B(+0.8%) |
| Jun 2001 | - | $2.99B(+2.7%) | $8.71B(+0.3%) |
| Mar 2001 | - | $2.91B(+3.1%) | $8.69B(-19.8%) |
| Sep 2000 | - | $2.82B(-4.9%) | $10.83B(-1.9%) |
| Jun 2000 | - | $2.96B(+5.2%) | $11.04B(-3.1%) |
| Mar 2000 | - | $2.82B(+26.2%) | $11.39B(+32.9%) |
| Dec 1999 | $11.89B(+28.0%) | $2.23B(-26.2%) | $8.57B(+35.2%) |
| Sep 1999 | - | $3.03B(-8.7%) | $6.34B(+91.3%) |
| Jun 1999 | - | $3.31B(+40.1%) | $3.31B(+40.1%) |
| Dec 1998 | $9.29B | - | - |
| Jun 1998 | - | $2.37B(+121.2%) | $2.37B(+121.2%) |
| Jun 1995 | - | $1.07B | $1.07B |
FAQ
- What is AstraZeneca annual gross profit?
- What is the all time high annual gross profit for AstraZeneca?
- What is AstraZeneca annual gross profit year-on-year change?
- What is AstraZeneca quarterly gross profit?
- What is the all time high quarterly gross profit for AstraZeneca?
- What is AstraZeneca quarterly gross profit year-on-year change?
- What is AstraZeneca TTM gross profit?
- What is the all time high TTM gross profit for AstraZeneca?
- What is AstraZeneca TTM gross profit year-on-year change?
What is AstraZeneca annual gross profit?
The current annual gross profit of AZN is $43.87B
What is the all time high annual gross profit for AstraZeneca?
AstraZeneca all-time high annual gross profit is $43.87B
What is AstraZeneca annual gross profit year-on-year change?
Over the past year, AZN annual gross profit has changed by +$6.32B (+16.84%)
What is AstraZeneca quarterly gross profit?
The current quarterly gross profit of AZN is $12.17B
What is the all time high quarterly gross profit for AstraZeneca?
AstraZeneca all-time high quarterly gross profit is $12.17B
What is AstraZeneca quarterly gross profit year-on-year change?
Over the past year, AZN quarterly gross profit has changed by $0.00 (0.00%)
What is AstraZeneca TTM gross profit?
The current TTM gross profit of AZN is $43.87B
What is the all time high TTM gross profit for AstraZeneca?
AstraZeneca all-time high TTM gross profit is $43.87B
What is AstraZeneca TTM gross profit year-on-year change?
Over the past year, AZN TTM gross profit has changed by $0.00 (0.00%)